nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—ALB—focal segmental glomerulosclerosis	0.559	1	CbGaD
Nortriptyline—CYP3A5—Cyclosporine—focal segmental glomerulosclerosis	0.0818	0.287	CbGbCtD
Nortriptyline—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.066	0.232	CbGbCtD
Nortriptyline—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0548	0.193	CbGbCtD
Nortriptyline—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.0501	0.176	CbGbCtD
Nortriptyline—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0319	0.112	CbGbCtD
Nortriptyline—Swollen tongue—Cyclosporine—focal segmental glomerulosclerosis	0.00665	0.0861	CcSEcCtD
Nortriptyline—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00269	0.0348	CcSEcCtD
Nortriptyline—Cholestasis—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.0333	CcSEcCtD
Nortriptyline—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.0322	CcSEcCtD
Nortriptyline—Tingling sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00243	0.0315	CcSEcCtD
Nortriptyline—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.0273	CcSEcCtD
Nortriptyline—Nightmare—Cyclosporine—focal segmental glomerulosclerosis	0.00189	0.0244	CcSEcCtD
Nortriptyline—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.0226	CcSEcCtD
Nortriptyline—Hepatic function abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.021	CcSEcCtD
Nortriptyline—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0205	CcSEcCtD
Nortriptyline—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00159	0.0205	CcSEcCtD
Nortriptyline—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.0203	CcSEcCtD
Nortriptyline—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00153	0.0198	CcSEcCtD
Nortriptyline—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00152	0.0196	CcSEcCtD
Nortriptyline—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.0195	CcSEcCtD
Nortriptyline—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00147	0.0191	CcSEcCtD
Nortriptyline—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.0182	CcSEcCtD
Nortriptyline—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00119	0.0155	CcSEcCtD
Nortriptyline—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.0147	CcSEcCtD
Nortriptyline—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00112	0.0144	CcSEcCtD
Nortriptyline—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.0144	CcSEcCtD
Nortriptyline—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.00108	0.014	CcSEcCtD
Nortriptyline—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0139	CcSEcCtD
Nortriptyline—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0139	CcSEcCtD
Nortriptyline—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0138	CcSEcCtD
Nortriptyline—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.00107	0.0138	CcSEcCtD
Nortriptyline—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000981	0.0127	CcSEcCtD
Nortriptyline—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000977	0.0126	CcSEcCtD
Nortriptyline—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000915	0.0118	CcSEcCtD
Nortriptyline—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.000911	0.0118	CcSEcCtD
Nortriptyline—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000877	0.0114	CcSEcCtD
Nortriptyline—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000867	0.0112	CcSEcCtD
Nortriptyline—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000838	0.0109	CcSEcCtD
Nortriptyline—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000837	0.0108	CcSEcCtD
Nortriptyline—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00083	0.0107	CcSEcCtD
Nortriptyline—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000805	0.0104	CcSEcCtD
Nortriptyline—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.0008	0.0104	CcSEcCtD
Nortriptyline—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000793	0.0103	CcSEcCtD
Nortriptyline—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000785	0.0102	CcSEcCtD
Nortriptyline—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00077	0.00998	CcSEcCtD
Nortriptyline—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000765	0.0099	CcSEcCtD
Nortriptyline—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00074	0.00959	CcSEcCtD
Nortriptyline—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000738	0.00955	CcSEcCtD
Nortriptyline—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00939	CcSEcCtD
Nortriptyline—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000719	0.00931	CcSEcCtD
Nortriptyline—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000711	0.00921	CcSEcCtD
Nortriptyline—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000703	0.0091	CcSEcCtD
Nortriptyline—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000697	0.00903	CcSEcCtD
Nortriptyline—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000683	0.00884	CcSEcCtD
Nortriptyline—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000674	0.00873	CcSEcCtD
Nortriptyline—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000665	0.00861	CcSEcCtD
Nortriptyline—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.00817	CcSEcCtD
Nortriptyline—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000626	0.00811	CcSEcCtD
Nortriptyline—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00062	0.00803	CcSEcCtD
Nortriptyline—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.00795	CcSEcCtD
Nortriptyline—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.000606	0.00785	CcSEcCtD
Nortriptyline—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000601	0.00778	CcSEcCtD
Nortriptyline—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.000596	0.00772	CcSEcCtD
Nortriptyline—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.000575	0.00744	CcSEcCtD
Nortriptyline—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000554	0.00717	CcSEcCtD
Nortriptyline—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.00714	CcSEcCtD
Nortriptyline—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000551	0.00714	CcSEcCtD
Nortriptyline—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000514	0.00665	CcSEcCtD
Nortriptyline—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.0005	0.00648	CcSEcCtD
Nortriptyline—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000493	0.00639	CcSEcCtD
Nortriptyline—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.000477	0.00618	CcSEcCtD
Nortriptyline—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000461	0.00597	CcSEcCtD
Nortriptyline—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000443	0.00574	CcSEcCtD
Nortriptyline—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.00569	CcSEcCtD
Nortriptyline—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000439	0.00569	CcSEcCtD
Nortriptyline—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000437	0.00566	CcSEcCtD
Nortriptyline—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000414	0.00536	CcSEcCtD
Nortriptyline—HTR1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.38e-05	0.000426	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.36e-05	0.000424	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.31e-05	0.000418	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—GNAQ—focal segmental glomerulosclerosis	3.28e-05	0.000414	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.27e-05	0.000413	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.26e-05	0.000411	CbGpPWpGaD
Nortriptyline—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	3.24e-05	0.00041	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	3.23e-05	0.000408	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.22e-05	0.000407	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	3.22e-05	0.000406	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.21e-05	0.000406	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.2e-05	0.000404	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	3.19e-05	0.000403	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.19e-05	0.000403	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.17e-05	0.0004	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.16e-05	0.000399	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CTGF—focal segmental glomerulosclerosis	3.16e-05	0.000399	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	3.15e-05	0.000398	CbGpPWpGaD
Nortriptyline—ALB—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	3.15e-05	0.000398	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.09e-05	0.000391	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—FN1—focal segmental glomerulosclerosis	3.09e-05	0.00039	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	3.08e-05	0.000389	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—NOS2—focal segmental glomerulosclerosis	3.05e-05	0.000385	CbGpPWpGaD
Nortriptyline—ALB—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.04e-05	0.000384	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.02e-05	0.000381	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—LIPC—focal segmental glomerulosclerosis	3.02e-05	0.000381	CbGpPWpGaD
Nortriptyline—DRD2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.99e-05	0.000378	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.98e-05	0.000377	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.98e-05	0.000376	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.97e-05	0.000376	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.97e-05	0.000374	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.95e-05	0.000372	CbGpPWpGaD
Nortriptyline—HTR2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.94e-05	0.000372	CbGpPWpGaD
Nortriptyline—HRH1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.94e-05	0.000371	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.93e-05	0.000371	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.93e-05	0.00037	CbGpPWpGaD
Nortriptyline—CHRM1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.93e-05	0.00037	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.92e-05	0.000369	CbGpPWpGaD
Nortriptyline—CHRM3—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.92e-05	0.000368	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.92e-05	0.000368	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.91e-05	0.000368	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.91e-05	0.000368	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.91e-05	0.000367	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.91e-05	0.000367	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.9e-05	0.000366	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.89e-05	0.000365	CbGpPWpGaD
Nortriptyline—CHRM2—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.89e-05	0.000365	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.89e-05	0.000364	CbGpPWpGaD
Nortriptyline—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	2.88e-05	0.000364	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.88e-05	0.000364	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	2.87e-05	0.000363	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.86e-05	0.000362	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	2.86e-05	0.000361	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.84e-05	0.000359	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.82e-05	0.000357	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.81e-05	0.000354	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.73e-05	0.000345	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.73e-05	0.000345	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.72e-05	0.000344	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.72e-05	0.000343	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.7e-05	0.000341	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.69e-05	0.000339	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.67e-05	0.000337	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.67e-05	0.000337	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.66e-05	0.000336	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.66e-05	0.000336	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CTGF—focal segmental glomerulosclerosis	2.65e-05	0.000335	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.65e-05	0.000335	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.62e-05	0.000331	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	2.62e-05	0.00033	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.61e-05	0.000329	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.6e-05	0.000328	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—LIPC—focal segmental glomerulosclerosis	2.6e-05	0.000328	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.58e-05	0.000326	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.58e-05	0.000326	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	2.57e-05	0.000325	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.53e-05	0.000319	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.49e-05	0.000315	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.49e-05	0.000315	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	2.49e-05	0.000314	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.47e-05	0.000312	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.47e-05	0.000312	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.47e-05	0.000312	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—LPL—focal segmental glomerulosclerosis	2.47e-05	0.000312	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.45e-05	0.00031	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.45e-05	0.000309	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.45e-05	0.000309	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.45e-05	0.000309	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.45e-05	0.000309	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.44e-05	0.000308	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.43e-05	0.000307	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.41e-05	0.000304	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	2.4e-05	0.000303	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—LIPC—focal segmental glomerulosclerosis	2.33e-05	0.000294	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.33e-05	0.000294	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.32e-05	0.000293	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CTGF—focal segmental glomerulosclerosis	2.29e-05	0.000289	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.28e-05	0.000288	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.28e-05	0.000288	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.24e-05	0.000283	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.24e-05	0.000283	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.23e-05	0.000282	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.23e-05	0.000282	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.22e-05	0.000281	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.2e-05	0.000278	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.2e-05	0.000278	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	2.2e-05	0.000277	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.19e-05	0.000277	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—LPL—focal segmental glomerulosclerosis	2.19e-05	0.000276	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.15e-05	0.000272	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—LIPC—focal segmental glomerulosclerosis	2.14e-05	0.000271	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.14e-05	0.00027	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	2.13e-05	0.000269	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—LIPC—focal segmental glomerulosclerosis	2.13e-05	0.000268	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.13e-05	0.000268	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—AGT—focal segmental glomerulosclerosis	2.11e-05	0.000267	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.11e-05	0.000266	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	2.1e-05	0.000265	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.1e-05	0.000265	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	2.1e-05	0.000265	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.06e-05	0.00026	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CTGF—focal segmental glomerulosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.03e-05	0.000257	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.02e-05	0.000255	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.01e-05	0.000254	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.94e-05	0.000245	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.93e-05	0.000244	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.93e-05	0.000243	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.91e-05	0.000241	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.9e-05	0.00024	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.9e-05	0.00024	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.9e-05	0.00024	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.89e-05	0.000239	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.89e-05	0.000239	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CTGF—focal segmental glomerulosclerosis	1.89e-05	0.000238	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.89e-05	0.000238	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.88e-05	0.000237	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—AGT—focal segmental glomerulosclerosis	1.87e-05	0.000236	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CTGF—focal segmental glomerulosclerosis	1.87e-05	0.000236	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.87e-05	0.000236	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	1.86e-05	0.000235	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.85e-05	0.000233	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—LPL—focal segmental glomerulosclerosis	1.84e-05	0.000233	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.84e-05	0.000233	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—LPL—focal segmental glomerulosclerosis	1.84e-05	0.000232	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.84e-05	0.000232	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.83e-05	0.000231	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.83e-05	0.000231	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.82e-05	0.00023	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LIPC—focal segmental glomerulosclerosis	1.82e-05	0.000229	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.81e-05	0.000229	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	1.81e-05	0.000228	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.79e-05	0.000226	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.78e-05	0.000224	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.75e-05	0.000221	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.74e-05	0.00022	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.73e-05	0.000219	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.72e-05	0.000218	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.72e-05	0.000217	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.71e-05	0.000216	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	1.71e-05	0.000216	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.69e-05	0.000213	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.68e-05	0.000212	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	1.63e-05	0.000206	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TGFB1—focal segmental glomerulosclerosis	1.62e-05	0.000205	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—ALB—focal segmental glomerulosclerosis	1.62e-05	0.000205	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.61e-05	0.000204	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.61e-05	0.000203	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.6e-05	0.000203	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CTGF—focal segmental glomerulosclerosis	1.6e-05	0.000202	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—LPL—focal segmental glomerulosclerosis	1.58e-05	0.0002	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000199	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000199	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.58e-05	0.000199	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—AGT—focal segmental glomerulosclerosis	1.57e-05	0.000199	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.57e-05	0.000198	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.57e-05	0.000198	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.55e-05	0.000196	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	1.55e-05	0.000195	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.48e-05	0.000187	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.47e-05	0.000186	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.46e-05	0.000184	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.46e-05	0.000184	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.45e-05	0.000184	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.45e-05	0.000183	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.45e-05	0.000183	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—ALB—focal segmental glomerulosclerosis	1.44e-05	0.000181	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.43e-05	0.000181	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	1.43e-05	0.00018	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—LPL—focal segmental glomerulosclerosis	1.42e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.41e-05	0.000177	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.4e-05	0.000177	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.4e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.37e-05	0.000173	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—AGT—focal segmental glomerulosclerosis	1.36e-05	0.000171	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.34e-05	0.000169	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.31e-05	0.000166	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—LPL—focal segmental glomerulosclerosis	1.31e-05	0.000165	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—LPL—focal segmental glomerulosclerosis	1.3e-05	0.000164	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.23e-05	0.000156	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.23e-05	0.000156	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.23e-05	0.000156	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—AGT—focal segmental glomerulosclerosis	1.22e-05	0.000154	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.21e-05	0.000153	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.21e-05	0.000153	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—ALB—focal segmental glomerulosclerosis	1.21e-05	0.000153	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—ALB—focal segmental glomerulosclerosis	1.21e-05	0.000153	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.21e-05	0.000152	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.2e-05	0.000152	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.2e-05	0.000151	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.19e-05	0.00015	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.19e-05	0.00015	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.14e-05	0.000144	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.13e-05	0.000143	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—AGT—focal segmental glomerulosclerosis	1.12e-05	0.000141	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—AGT—focal segmental glomerulosclerosis	1.11e-05	0.00014	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—LPL—focal segmental glomerulosclerosis	1.11e-05	0.00014	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.08e-05	0.000137	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.08e-05	0.000136	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.07e-05	0.000135	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.02e-05	0.000129	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.02e-05	0.000129	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—AGT—focal segmental glomerulosclerosis	9.48e-06	0.00012	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.45e-06	0.000119	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—ALB—focal segmental glomerulosclerosis	9.34e-06	0.000118	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.3e-06	0.000117	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.28e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.25e-06	0.000117	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.22e-06	0.000116	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.13e-06	0.000115	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	9.1e-06	0.000115	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.87e-06	0.000112	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.82e-06	0.000111	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—ALB—focal segmental glomerulosclerosis	8.59e-06	0.000108	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	8.55e-06	0.000108	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—ALB—focal segmental glomerulosclerosis	8.52e-06	0.000108	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	8.45e-06	0.000107	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.79e-06	9.83e-05	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.66e-06	9.68e-05	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.65e-06	9.65e-05	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.62e-06	9.62e-05	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.6e-06	9.59e-05	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.52e-06	9.5e-05	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	7.5e-06	9.47e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	7.32e-06	9.24e-05	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—ALB—focal segmental glomerulosclerosis	7.28e-06	9.19e-05	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	5.62e-06	7.09e-05	CbGpPWpGaD
